Research on Mechanisms of Appetite-regulating Peptides

ZHANG Guohua; QI Qianhui; WANG Wei; YANG Hua

doi:10.13386/j.issn1002-0306.2020050376

Volume 42 Issue 5

Feb. 2021

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2021 > 42(5): 369-377,382. > DOI: 10.13386/j.issn1002-0306.2020050376

ZHANG Guohua, QI Qianhui, WANG Wei, YANG Hua. Research on Mechanisms of Appetite-regulating Peptides[J]. Science and Technology of Food Industry, 2021, 42(5): 369-377,382. DOI: 10.13386/j.issn1002-0306.2020050376

Citation:

PDF (2081 KB)

Research on Mechanisms of Appetite-regulating Peptides

1. School of Life Science, Shanxi University, Taiyuan 030006, China;
2. Institute of Agricultural Products Quality Standard, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China

More Information

Received Date: May 31, 2020
Available Online: March 02, 2021

Graphical Abstract

Abstract

Abstract

Appetite-regulating peptides are a class of polypeptides which can regulate appetite. They are mainly distributed in peripheral tissues such as the stomach and intestines,as well as in the hypothalamus. They can be divided into appetite-stimulating peptides and appetite-suppressing peptides according to their different mechanisms. The hypothalamus plays an important role in the process of appetite regulation,and its communication with peripheral tissues such as stomach and intestinal tract is an important way of appetite regulation. Our review discusses four appetite signaling pathways such as neuropeptide Y(NPY),ghrelin,peptide YY(PYY),leptin and the relationship between food and appetite-regulation peptides. Using mathematical and statistical methods can explore hot issues and their relationships in appetite regulation. This helps to understand the mechanism and research status in appetite-regulating peptides,in order to regulate appetite through diet,prevent the happening of the disease,and can provide references for further research on appetite regulation.
- appetite-regulating peptides,
- neuropeptide Y(NPY),
- peptide YY(PYY),
- ghrelin,
- leptin

FullText(HTML)

References (86)

References

[1]	Hetterich L,Mack I,Giel K E,et al. An update on gastrointestinal disturbances in eating disorders[J]. Molecular and Cellular Endocrinology,2019,497:110318.
[2]	Hall J E,do Carmo J M,da Silva A A,et al. Obesity,kidney dysfunction and hypertension:Mechanistic links[J]. Nature Reviews Nephrology,2019,15(6):367-385.
[3]	Klil-Drori A J,Azoulay L,Pollak M N. Cancer,obesity,diabetes,and antidiabetic drugs:Is the fog clearing?[J]. Nature Reviews. Clinical Oncology,2017,14(2):85-99.
[4]	Kim S H,Després J P,Koh K K. Obesity and cardiovascular disease:friend or foe?[J]. European Heart Journal,2015,37(48):3560-3568.
[5]	Smith K B,Smith M S. Obesity statistics[J]. Primary Care,2016,43(1):121-135.
[6]	陆翼飞. 进食障碍诊疗新进展及其对全科治疗的启示[J].名医,2019,11:47.
[7]	Heruc G A,Little T J,Kohn M,et al. Appetite perceptions,gastrointestinal symptoms,ghrelin,peptide yy and state anxiety are disturbed in adolescent females with anorexia nervosa and only partially restored with short-term refeeding[J]. Nutrients,2019,11(1):59.
[8]	Mancuso C,Izquierdo A,Slattery M,et al. Changes in appetite-regulating hormones following food intake are associated with changes in reported appetite and a measure of hedonic eating in girls and young women with anorexia nervosa[J]. Psychoneuroendocrinology,2020,113:104556.
[9]	Steinert R E,Feinle-Bisset C,Asarian L,et al. Ghrelin,CCK,GLP-1,and PYY(3-36):Secretory controls and physiological roles in eating and glycemia in health,obesity,and after rygb[J]. Physiological Reviews,2017,97(1):411-463.
[10]	Mingrone G,Panunzi S,De Gaetano A,et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes:5 year follow-up of an open-label,single-centre,randomised controlled trial[J]. Lancet,2015,386(9997):964-973.
[11]	Schauer P R,Bhatt D L,Kirwan J P,et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes[J]. New England Journal of Medicine,2014,370(21):2002-2013.
[12]	Carabotti M,Scirocco A,Maselli M A,et al. The gut-brain axis:Interactions between enteric microbiota,central and enteric nervous systems[J]. Annals of Gastroenterology,2015,28(2):203-209.
[13]	Clemmensen C,Muller T D,Woods S C,et al. Gut-brain cross-talk in metabolic control[J]. Cell,2017,168(5):758-774.
[14]	Waterson M J,Horvath T L. Neuronal regulation of energy homeostasis:Beyond the hypothalamus and feeding[J]. Cell Metabolism,2015,22(6):962-970.
[15]	Suzuki K,Simpson K A,Minnion J S,et al. The role of gut hormones and the hypothalamus in appetite regulation[J]. Endocrine Journal,2010,57(5):359-372.
[16]	Elmquist J K,Elias C F,Saper C B. From lesions to leptin:hypothalamic control of food intake and body weight[J]. Neuron,1999,22(2):221-232.
[17]	Schaeffer M,Langlet F,Lafont C,et al. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons[J]. Proceedings of the National Academy of Sciences of the United States of America,2013,110(4):1512-1517.
[18]	Huston N J,Brenner L A,Taylor Z C,et al. NPY2 receptor activation in the dorsal vagal complex increases food intake and attenuates CCK-induced satiation in male rats[J]. American Journal of Physiology,Regulatory,Integrative and Comparative Physiology,2019,316(4):R406-R416.
[19]	Holzer P,Reichmann F,Farzi A. Neuropeptide Y,peptide YY and pancreatic polypeptide in the gut-brain axis[J]. Neuropeptides,2012,46(6):261-274.
[20]	Keire D A,Mannon P,Kobayashi M,et al. Primary structures of PYY,[Pro34]PYY,and PYY-(3-36)confer different conformations and receptor selectivity[J]. Journal of Physiology-Gastrointestinal and Liver Physiology,2000,279(1):G126-G131.
[21]	Yulyaningsih E,Zhang L,Herzog H,et al. NPY receptors as potential targets for anti-obesity drug development[J]. British Journal of Pharmacology,2011,163(6):1170-1202.
[22]	Batterham R L,Cowley M A,Small C J,et al. Gut hormone PYY3-36 physiologically inhibits food intake[J]. Nature,2002,418(6898):650-654.
[23]	Abbott C R,Small C J,Kennedy A R,et al. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BⅡE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36)on food intake[J]. Brain Research,2005,1043(1):139-144.
[24]	Batterham R L,Cohen M A,Ellis S M,et al. Inhibition of food intake in obese subjects by peptide YY3-36[J]. New England Journal of Medicine,2003,349(10):941-948.
[25]	Koda S,Date Y,Murakami N,et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats[J]. Endocrinology,2005,146(5):2369-2375.
[26]	Kjaergaard M,Salinas C B G,Rehfeld J F,et al. PYY(3-36)and exendin-4 reduce food intake and activate neuronal circuits in a synergistic manner in mice[J]. Neuropeptides,2019,73:89-95.
[27]	Yan P,Jia J,Yang G,et al. Duplication of neuropeptide Y and peptide YY in Nile tilapia Oreochromis niloticus and their roles in food intake regulation[J]. Peptides,2017,88:97-105.
[28]	Teubner B J W,Bartness T J. PYY(3-36)into the arcuate nucleus inhibits food deprivation-induced increases in food hoarding and intake[J]. Peptides,2013,47:20-28.
[29]	Suzuki Y,Nakahara K,Maruyama K,et al. Changes in mRNA expression of arcuate nucleus appetite-regulating peptides during lactation in rats[J]. Journal of Molecular Endocrinology,2014,52(2):97-109.
[30]	Alhadeff A L,Golub D,Hayes M R,et al. Peptide YY signaling in the lateral parabrachial nucleus increases food intake through the Y1 receptor[J]. American Journal of Physiology-Endocrinology and Metabolism,2015,309(8):E759-E766.
[31]	Adrian T E,Savage A P,Sagor G R,et al. Effect of peptide YY on gastric,pancreatic,and biliary function in humans[J]. Gastroenterology,1985,89(3):494-499.
[32]	Grandt D,Schimiczek M,Beglinger C,et al. Two molecular forms of peptide YY(PYY)are abundant in human blood:Characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36[J]. Regulatory Peptides,1994,51(2):151-159.
[33]	Larraufie P,Martin-Gallausiaux C,Lapaque N,et al. SCFAs strongly stimulate PYY production in human enteroendocrine cells[J]. Scientific Reports 2018,8(1):74.
[34]	Tam F I,Seidel M,Boehm I,et al. Peptide YY3-36 concentration in acute-and long-term recovered anorexia nervosa[J]. European Journal of Nutrition,2020.
[35]	Nakamura Y,Yanagawa Y,Morrison S F,et al. Medullary reticular neurons mediate neuropeptide y-induced metabolic inhibition and mastication[J]. Cell Metabolism,2017,25(2):322-334.
[36]	Chambers A P,Woods S C. The role of neuropeptide Y in energy homeostasis[J]. Handbook of Experimental Pharmacology,2012.
[37]	Loh K,Herzog H,Shi Y C. Regulation of energy homeostasis by the NPY system[J]. Trends in Endocrinology and Metabolism,2015,26(3):125-135.
[38]	Tatemoto K,Carlquist M,Mutt V. Neuropeptide Y——a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide[J]. Nature,1982,296(5858):659-660.
[39]	Adrian T E,Allen J M,Bloom S R,et al. Neuropeptide Y distribution in human brain[J]. Nature,1983,306(5943):584-586.
[40]	Shi Y C,Lau J,Lin Z,et al. Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN[J]. Cell Metabolism,2013,17(2):236-248.
[41]	Mercer R E,Chee M J,Colmers W F. The role of NPY in hypothalamic mediated food intake[J]. Frontiers in Neuroendocrinology,2011,32(4):398-415.
[42]	Yuan D Y,Gao Y D,Zhang X,et al. NPY and NPY receptors in the central control of feeding and interactions with CART and MC4R in Siberian sturgeon[J]. General and Comparative Endocrinology,2019,284:8.
[43]	Michel M C,Beck-Sickinger A,Cox H,et al. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y,peptide YY,and pancreatic polypeptide receptors[J]. Pharmacological Reviews,1998,50(1):143-150.
[44]	Acuna-Goycolea C,Tamamaki N,Yanagawa Y,et al. Mechanisms of neuropeptide Y,peptide YY,and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus[J]. Journal of Neuroscience Methods,2005,25(32):7406-7419.
[45]	Kamiji M M,Inui A. Neuropeptide Y receptor selective ligands in the treatment of obesity[J]. Endocrine Reviews,2007,28(6):664-684.
[46]	Fukasaka Y,Nambu H,Tanioka H,et al. An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese mice[J]. Neuropeptides,2018,70:55-63.
[47]	Lin S,Boey D,Herzog H. NPY and Y receptors:lessons from transgenic and knockout models[J]. Neuropeptides,2004,38(4):189-200.
[48]	Herzog H,Darby K,Ball H,et al. Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation[J]. Genomics,1997,41(3):315-319.
[49]	Dube M G,Xu B,Crowley W R,et al. Evidence that neuropeptide-y is a physiological signal for normal food-intake[J]. Brain Research,1994,646(2):341-344.
[50]	Yokobori E,Azuma M,Nishiguchi R,et al. Neuropeptide y stimulates food intake in the zebrafish,danio rerio[J]. Journal of Neuroendocrinology,2012,24(5):766-773.
[51]	Kohno D,Sone H,Tanaka S,et al. AMP-activated protein kinase activates neuropeptide Y neurons in the hypothalamic arcuate nucleus to increase food intake in rats[J]. Neuroscience Letters,2011,499(3):194-198.
[52]	Baranowska B,Wolinska-Witort E,Martynska M,et al. Plasma orexin A,orexin B,leptin,neuropeptide Y(NPY)and insulin in obese women[J]. Neuroendocrinology Letters,2005,26(6):628-628.
[53]	Kawai K,Nakashima M,Kojima M,et al. Ghrelin activation and neuropeptide Y elevation in response to medium chain triglyceride administration in anorexia nervosa patients[J]. Clinical Nutrition ESPEN,2017,17:100-104.
[54]	Chatree S,Sitticharoon C,Maikaew P,et al. Adipose Y5R mRNA is higher in obese than non-obese humans and is correlated with obesity parameters[J]. Experimental Biology and Medicine,2018,243(9):786-795.
[55]	Kojima M,Hosoda H,Date Y,et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach[J]. Nature,1999,402(6762):656-660.
[56]	Yanagi S,Sato T,Kangawa K,et al. The homeostatic force of ghrelin[J]. Cell Metabolism,2018,27(4):786-804.
[57]	Willesen M G,Kristensen P,Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat[J]. Neuroendocrinology,1999,70(5):306-316.
[58]	Tschop M,Smiley D L,Heiman M L. Ghrelin induces adiposity in rodents[J]. Nature,2000,407(6806):908-913.
[59]	Nakazato M,Murakami N,Date Y,et al. A role for ghrelin in the central regulation of feeding[J]. Nature,2001,409(6817):194-198.
[60]	Schellekens H,De Francesco P N,Kandil D,et al. Ghrelin's orexigenic effect is modulated via a serotonin 2C receptor interaction[J]. ACS Chemical Neuroscience,2015,6(7):1186-1197.
[61]	dos-Santos R C,Grover H M,Reis L C,et al. Electrophysiological effects of ghrelin in the hypothalamic paraventricular nucleus neurons[J]. Frontiers in Cellular Neuroscience,2018,12:275.
[62]	Elabadlah H,Hameed R,D'Souza C,et al. Exogenous ghrelin increases plasma insulin level in diabetic rats[J]. Biomolecules,2020,10(4):633.
[63]	Sharma G,Nain P S,Sethi P,et al. Plasma ghrelin levels after laparoscopic sleeve gastrectomy in obese individuals[J]. The Indian Journal of Medical Research,2019,149(4):544-547.
[64]	Nuran K,Zerrin O,Cahit K,et al. The effect of therapy on plasma ghrelin and leptin levels,and appetite in children with iron deficiency anemia[J]. Journal of Pediatric Endocrinology and Metabolism,2019,32(3):275-280.
[65]	Varda N M,Medved M,Ojsteršek L. The associations between some biological markers,obesity,and cardiovascular risk in Slovenian children and adolescents[J]. BMC Pediatrics,2020,20(1):81-81.
[66]	Saladin R,De Vos P,Guerre-Millo M,et al. Transient increase in obese gene expression after food intake or insulin administration[J]. Nature,1995,377(6549):527-529.
[67]	Saad M F,Riad-Gabriel M G,Khan A,et al. Diurnal and ultradian rhythmicity of plasma leptin:Effects of gender and adiposity[J]. Journal of Clinical Endocrinology & Metabolism,1998,83(2):453-459.
[68]	Ferrao R D,Wallweber H J,Lupardus P J. Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation[J]. ELife,2018,7:e38089.
[69]	Pedroso J A B,Ramos-Lobo A M,Donato J. SOCS3 as a future target to treat metabolic disorders[J]. Hormones-International Journal of Endocrinology and Metabolism,2019,18(2):127-136.
[70]	Barrios-Correa A A,Estrada J A,Contreras I. Leptin signaling in the control of metabolism and appetite:Lessons from animal models[J]. Journal of Molecular Neuroscience,2018,66(3):390-402.
[71]	戚宇琪,郭杰,郭晓霞. 基于POMC/AgRP神经元探讨瘦素调节食欲的作用机制[J]. 医学综述,2019,25(23):4646-4651.
[72]	Frederich R C,Hamann A,Anderson S,et al. Leptin levels reflect body lipid-content in mice-evidence for diet-induced resistance to leptin action[J]. Nature Medicine,1995,1(12):1311-1314.
[73]	Zhao S,Kusminski C M,Elmquist J K,et al. Leptin:Less is more[J]. Diabetes,2020,69(5):823-829.
[74]	Munzberg H. Leptin-signaling pathways and leptin resistance[J]. Frontiers in Eating and Weight Regulation,2010,63:123-132.
[75]	Banks W A. Anorectic effects of circulating cytokines:role of the vascular blood-brain barrier[J]. Nutrition,2001,17(5):434-437.
[76]	Zhao S,Zhu Y,Schultz R D,et al. Partial leptin reduction as an insulin sensitization and weight loss strategy[J]. Cell Metabolism,2019,30(4):706-719.
[77]	Sims W,Yi J Q,Cline M A,et al. Central injection of a synthetic chicken partial leptin peptide does not affect food intake in chicks[J]. Neuroscience Letters,2017,656:165-168.
[78]	Farooqi I S,Matarese G,Lord G M,et al. Beneficial effects of leptin on obesity,T cell hyporesponsiveness,and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency[J]. Journal of Clinical Investigation,2002,110(8):1093-1103.
[79]	Paz-Filho G,Mastronardi C A,Licinio J. Leptin treatment:Facts and expectations[J]. Metabolism-Clinical and Experimental,2015,64(1):146-156.
[80]	Parandoosh M,Yousefi R,Khorsandi H,et al. The effects of grape seed extract(Vitis vinifera)supplement on inflammatory markers,neuropeptide Y,anthropometric measures,and appetite in obese or overweight individuals:A randomized clinical trial[J]. Phytotherapy Research,2020,34(2):379-387.
[81]	Hansson P,Holven K B,Øyri L K L,et al. Dairy products influence gut hormone secretion and appetite differently:A randomized controlled crossover trial[J]. Journal of Dairy Science,2020,103(2):1100-1109.
[82]	Wolever T M S,Tosh S M,Spruill S E,et al. Increasing oat β-glucan viscosity in a breakfast meal slows gastric emptying and reduces glycemic and insulinemic responses but has no effect on appetite,food intake,or plasma ghrelin and PYY responses in healthy humans:A randomized,placebo-controlled,crossover trial[J]. The American Journal of Clinical Nutrition,2019,111(2):319-328.
[83]	Chan C K Y,Fabek H,Mollard R C,et al. Faba bean protein flours added to pasta reduce post-ingestion glycaemia,and increase satiety,protein content and quality[J]. Food & Function,2019,10(11):7476-7488.
[84]	王睿,张宁宁,毛极仁. 酪蛋白巨肽的生物学活性及对食欲的调节作用[J]. 食品研究与开发,2018,19(39):197-201.
[85]	Chen W Y,Hira T,Nakajima S,et al. Wheat gluten hydrolysate potently stimulates peptide-YY secretion and suppresses food intake in rats[J]. Bioscience Biotechnology and Biochemistry,2018,82(11):1992-1999.
[86]	陈文雅. 食欲的调控机理及膳食蛋白对其产生的影响[J]. 现代食品,2017,20:72-77.

Supplements (0)

Cited By

Cited by

Periodical cited type(10)

1.	严鹤松，段坦，雷晶晶，王佳，张晓曼，李玥，舒玉凤，李婵娟. Caldicellulosiruptor owensensis木聚糖酶的融合表达、酶学性质研究及在面包烘焙中的应用. 食品与发酵工业. 2024(14): 120-125 .
2.	张玉玺，刘星宇，齐肖亚，饶欢，赵丹丹，郝建雄，刘学强. 耐热小麦阿拉伯木聚糖酶Xyn11A在全麦面包品质改良中的应用. 食品工业科技. 2024(24): 82-89 . 本站查看
3.	杨行，马俊文，李延啸，江正强，刘学强，闫巧娟. 毛壳霉木聚糖酶B(CsXyn11B)的分泌表达及其在面包中的应用. 食品工业科技. 2023(04): 108-113 . 本站查看
4.	徐卓越，詹磊，王玉牛，李紫华，詹忆维，陈佩. 三种食品添加剂对粉圆抗老化特性的研究. 中国食品添加剂. 2023(02): 197-202 .
5.	洪静，郭婉雪，郑学玲，李盘欣，王红新，黄亚男. 不同加工方式的淀粉质食品老化的影响因素和延缓老化方法的研究进展. 河南工业大学学报(自然科学版). 2023(02): 127-133 .
6.	于章龙，刘瑞，蔡岳，宋昱，孙元琳，关硕. 运黑161全麦粉面包配方研究. 山西农业大学学报(自然科学版). 2023(04): 107-119 .
7.	孙力博，刘远晓，李萌萌，关二旗，卞科. 发酵面团持气性及品质改良研究进展. 食品与发酵工业. 2023(20): 323-330 .
8.	刘玉春，张维清，任菲，郭超，王超. 裂褶菌极端嗜盐木聚糖酶ScXyn22的性质及对全麦面包品质的影响. 食品科学. 2022(18): 127-133 .
9.	张露晶，张昕茹，王鑫. 添加食用菌发酵液的全麦面包的研究进展. 中国食用菌. 2021(04): 104-107+112 .
10.	陈艳红，郑胜蓝，李慧雪，李利君，倪辉. 全麦粉面包生产工艺优化. 食品与机械. 2021(11): 173-177 .